Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business Update

Go back to Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business Update
(NASDAQ: FENC) Delayed: 12.45 +0.06 (0.48%)
Previous Close $12.39    52 Week High
Open $12.16    52 Week Low
Day High $12.53    P/E N/A 
Day Low $12.08    EPS
Volume 256,278       

Forest Laboratories (NYSE: FRX) Delayed: 12.00 --0 (-0%)
Previous Close $12.00    52 Week High $100.88 
Open $24.87    52 Week Low $64.33 
Day High $12.00    P/E 20.69 
Day Low $12.00    EPS $0.58 
Volume 20